Patients with inflammatory bowel diseases (IBDs) such as Crohn’s disease or ulcerative colitis do perceive a benefit from thiopurine treatment. A report in the open access journal BMC Gastroenterology has demonstrated improved health-related quality of life in 92 IBD patients. Guillermo Bastida worked with a team of researchers from La Fe Hospital, Valencia, Spain, to investigate the controversial thiopurine treatment. He said, “The efficacy of thiopurines in the scenarios in which they are prescribed, either to induce or to maintain remission in IBD, is well proven…

Continued here: 
Thiopurine Therapy For IBD Improves Quality Of Life

You may also like:

• Hearing Loss In Men Increased By Regular Analgesic Use
• Early Warning Signs For Future Heart Disease Found In Obese 3-Year-olds
• Thiopurine Therapy For IBD Improves Quality Of Life
• Childhood Obesity Prevention Should Begin Early In Life, Possibly Before Birth
• Childhood Obesity Prevention Should Begin Early In Life, Possibly Before Birth
• Scientists identify natural anti-cancer defenses
• Long-Term Data On Cimzia(R) (certolizumab Pegol) For Moderate To Severe Crohn’s Disease To Be Highlighted At Upcoming DDW Meeting
• Hearing Loss In Men Increased By Regular Analgesic Use
• Distinct Demographic Profiles Between Crohn’s Disease And Ulcerative Colitis
• Breakthrough On Causes Of Inflammatory Bowel Disease